Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 435

1.

Digoxin-mortality: randomized vs. observational comparison in the DIG trial.

Aguirre Dávila L, Weber K, Bavendiek U, Bauersachs J, Wittes J, Yusuf S, Koch A.

Eur Heart J. 2019 Jun 18. pii: ehz395. doi: 10.1093/eurheartj/ehz395. [Epub ahead of print]

PMID:
31211324
2.

Left heart function in COPD : Impact of lung deflation.

Struß N, Bauersachs J, Welte T, Hohlfeld JM.

Herz. 2019 Jun 11. doi: 10.1007/s00059-019-4816-5. [Epub ahead of print]

PMID:
31187193
3.

Initial experience with telemonitoring in left ventricular assist device patients.

Hohmann S, Veltmann C, Duncker D, König T, Berliner D, Hanke J, Dogan G, Chatterjee A, Feldmann C, Lynch B, Burkhoff D, Haverich A, Bauersachs J, Schmitto JD.

J Thorac Dis. 2019 Apr;11(Suppl 6):S853-S863. doi: 10.21037/jtd.2018.10.37.

4.

The transcription factor GATA4 promotes myocardial regeneration in neonatal mice.

Malek Mohammadi M, Kattih B, Grund A, Froese N, Korf-Klingebiel M, Gigina A, Schrameck U, Rudat C, Liang Q, Kispert A, Wollert KC, Bauersachs J, Heineke J.

EMBO Mol Med. 2019 Jun;11(6). pii: e10678. doi: 10.15252/emmm.201910678. No abstract available.

5.

Extracorporeal membrane oxygenation for ARDS due to Pneumocystis pneumonia.

Stahl K, Schenk H, Seeliger B, Wiesner O, Schmidt JJ, Bauersachs J, Welte T, Kühn C, Haverich A, Hoeper MM, David S.

Eur Respir J. 2019 May 31. pii: 1900410. doi: 10.1183/13993003.00410-2019. [Epub ahead of print] No abstract available.

PMID:
31151957
6.

Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology.

Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, de Boer RA, Drexel H, Ben Gal T, Hill L, Jaarsma T, Jankowska EA, Anker MS, Lainscak M, Lewis BS, McDonagh T, Metra M, Milicic D, Mullens W, Piepoli MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJS.

Eur J Heart Fail. 2019 May 26. doi: 10.1002/ejhf.1531. [Epub ahead of print]

PMID:
31129923
7.

Letter by Hilfiker-Kleiner et al Regarding Article, "Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes".

Hilfiker-Kleiner D, Sliwa K, Bauersachs J.

Circulation. 2019 May 21;139(21):e990-e991. doi: 10.1161/CIRCULATIONAHA.118.039234. No abstract available.

PMID:
31107614
8.

New drugs: big changes in conservative heart failure therapy?

Berliner D, Bauersachs J.

Eur J Cardiothorac Surg. 2019 Jun 1;55(Supplement_1):i3-i10. doi: 10.1093/ejcts/ezy421.

9.

Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry.

Gili S, Cammann VL, Schlossbauer SA, Kato K, D'Ascenzo F, Di Vece D, Jurisic S, Micek J, Obeid S, Bacchi B, Szawan KA, Famos F, Sarcon A, Levinson R, Ding KJ, Seifert B, Lenoir O, Bossone E, Citro R, Franke J, Napp LC, Jaguszewski M, Noutsias M, Münzel T, Knorr M, Heiner S, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Gilyarova E, Shilova A, Gilyarov M, Horowitz JD, Kozel M, Tousek P, Widimský P, Winchester DE, Ukena C, Gaita F, Di Mario C, Wischnewsky MB, Bax JJ, Prasad A, Böhm M, Ruschitzka F, Lüscher TF, Ghadri JR, Templin C.

Eur Heart J. 2019 May 16. pii: ehz170. doi: 10.1093/eurheartj/ehz170. [Epub ahead of print]

PMID:
31098611
10.

[Oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation after coronary interventions].

Schäfer A, Bauersachs J.

Herz. 2019 Jun;44(4):365-378. doi: 10.1007/s00059-019-4811-x. German.

PMID:
31087108
11.

Effects of personalized endurance training on cellular age and vascular function in middle-aged sedentary women.

Eigendorf J, Melk A, Haufe S, Boethig D, Berliner D, Kerling A, Kueck M, Stenner H, Bara C, Stiesch M, Schippert C, Hilfiker A, Falk C, Bauersachs J, Thum T, Lichtinghagen R, Haverich A, Hilfiker-Kleiner D, Tegtbur U.

Eur J Prev Cardiol. 2019 May 13:2047487319849505. doi: 10.1177/2047487319849505. [Epub ahead of print] No abstract available.

PMID:
31084260
12.

Prediction of heart failure and death in an adult population of Fontan patients.

Sieweke JT, Haghikia A, Riehle C, Klages C, Akin M, König T, Zwadlo C, Treptau J, Schäfer A, Bauersachs J, Westhoff-Bleck M.

Cardiol Young. 2019 May;29(5):602-609. doi: 10.1017/S1047951119000258. Epub 2019 Apr 30.

PMID:
31036097
13.

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.

Seferović PM, Polovina M, Bauersachs J, Arad M, Gal TB, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D, Filippatos GS, Gialafos E, Kanjuh V, Krljanac G, Limongelli G, Linhart A, Lyon AR, Maksimović R, Miličić D, Milinković I, Noutsias M, Oto A, Oto Ö, Pavlović SU, Piepoli MF, Ristić AD, Rosano GMC, Seggewiss H, Ašanin M, Seferović JP, Ruschitzka F, Čelutkiene J, Jaarsma T, Mueller C, Moura B, Hill L, Volterrani M, Lopatin Y, Metra M, Backs J, Mullens W, Chioncel O, de Boer RA, Anker S, Rapezzi C, Coats AJS, Tschöpe C.

Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16.

PMID:
30989768
14.

The continuous heart failure spectrum: moving beyond an ejection fraction classification.

Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW.

Eur Heart J. 2019 Apr 8. pii: ehz158. doi: 10.1093/eurheartj/ehz158. [Epub ahead of print]

PMID:
30957868
15.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA.

Kardiol Pol. 2019;77(3):245-326. doi: 10.5603/KP.2019.0049. No abstract available.

16.

Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.

Bavendiek U, Berliner D, Dávila LA, Schwab J, Maier L, Philipp SA, Rieth A, Westenfeld R, Piorkowski C, Weber K, Hänselmann A, Oldhafer M, Schallhorn S, von der Leyen H, Schröder C, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J; DIGIT-HF Investigators and Committees (see Appendix).

Eur J Heart Fail. 2019 May;21(5):676-684. doi: 10.1002/ejhf.1452. Epub 2019 Mar 20.

PMID:
30892806
17.

Haemodynamic simulation and the effect of early left ventricular unloading in pre-shock acute coronary syndrome.

Schäfer A, Burkhoff D, Bauersachs J.

ESC Heart Fail. 2019 Jun;6(3):457-463. doi: 10.1002/ehf2.12417. Epub 2019 Mar 12.

18.

Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury.

Sonnenschein K, Fiedler J, Pfanne A, Just A, Mitzka S, Geffers RR, Pich A, Bauersachs J, Thum T.

Cardiovasc Res. 2019 Mar 7. pii: cvz063. doi: 10.1093/cvr/cvz063. [Epub ahead of print]

PMID:
30843048
19.

Multimodal Elimination for Intoxication with a Lethal Dose of Organic Mercury.

Napp LC, Moelgen C, Wegner F, Heitland P, Koester HD, Klintschar M, Hiss M, Schaper A, Schieffer B, Bauersachs J, Schäfer A, Tongers J.

Case Rep Crit Care. 2019 Jan 16;2019:4275918. doi: 10.1155/2019/4275918. eCollection 2019.

20.

Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism.

Ius F, Hoeper MM, Fegbeutel C, Kühn C, Olsson K, Koigeldiyev N, Tudorache I, Warnecke G, Optenhöfel J, Puntigam JO, Schäfer A, Meyer BC, Hinrichs JB, Bauersachs J, Haverich A, Cebotari S.

Eur Respir J. 2019 Apr 25;53(4). pii: 1801773. doi: 10.1183/13993003.01773-2018. Print 2019 Apr. No abstract available.

PMID:
30728206
21.

Key inflammatory mechanisms underlying heart failure.

Riehle C, Bauersachs J.

Herz. 2019 Apr;44(2):96-106. doi: 10.1007/s00059-019-4785-8.

22.

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology.

de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, McDonagh T, Lopez-Andres N, Lunde IG, Lyon AR, Pollesello P, Prasad SK, Tocchetti CG, Mayr M, Sluijter JPG, Thum T, Tschöpe C, Zannad F, Zimmermann WH, Ruschitzka F, Filippatos G, Lindsey ML, Maack C, Heymans S.

Eur J Heart Fail. 2019 Mar;21(3):272-285. doi: 10.1002/ejhf.1406. Epub 2019 Feb 4.

23.

C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.

Wang Y, Dembowsky K, Chevalier E, Stüve P, Korf-Klingebiel M, Lochner M, Napp LC, Frank H, Brinkmann E, Kanwischer A, Bauersachs J, Gyöngyösi M, Sparwasser T, Wollert KC.

Circulation. 2019 Apr 9;139(15):1798-1812. doi: 10.1161/CIRCULATIONAHA.118.036053.

24.

Safe Exchange of a Transfemoral Impella Pump.

Tongers J, Flierl U, Sieweke JT, Bauersachs J, Schäfer A, Napp LC.

Cardiovasc Revasc Med. 2018 Dec 19. pii: S1553-8389(18)30609-2. doi: 10.1016/j.carrev.2018.12.006. [Epub ahead of print]

PMID:
30651215
25.

Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial.

Vogel-Claussen J, Schönfeld CO, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, Tillmann HC, Berschneider K, Hiltl S, Bauersachs J, Welte T, Hohlfeld JM.

Am J Respir Crit Care Med. 2019 May 1;199(9):1086-1096. doi: 10.1164/rccm.201805-0995OC.

PMID:
30641027
26.

Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome.

Di Vece D, Citro R, Cammann VL, Kato K, Gili S, Szawan KA, Micek J, Jurisic S, Ding KJ, Bacchi B, Schwyzer M, Candreva A, Bossone E, D'Ascenzo F, Sarcon A, Franke J, Napp LC, Jaguszewski M, Noutsias M, Münzel T, Knorr M, Heiner S, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuβ G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Gilyarova E, Shilova A, Gilyarov M, Horowitz J, Kozel M, Tousek P, Widimský P, Winchester DE, Ukena C, Di Mario C, Prasad A, Böhm M, Bax JJ, Lüscher TF, Ruschitzka F, Ghadri JR, Templin C.

Circulation. 2019 Jan 15;139(3):413-415. doi: 10.1161/CIRCULATIONAHA.118.036164. No abstract available.

PMID:
30586690
27.

The No-Win Resuscitation: Ventricular Septal Rupture and Associated Acute Aortic Occlusion.

Sieweke JT, Vogel-Claussen J, Martens A, Tongers J, Schäfer A, Bauersachs J, Napp LC.

Case Rep Crit Care. 2018 Nov 19;2018:1568491. doi: 10.1155/2018/1568491. eCollection 2018.

28.

Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing.

Fraccarollo D, Thomas S, Scholz CJ, Hilfiker-Kleiner D, Galuppo P, Bauersachs J.

Hypertension. 2019 Jan;73(1):102-111. doi: 10.1161/HYPERTENSIONAHA.118.12162.

29.

Plasma Concentrations of Myeloid-Derived Growth Factor in Healthy Individuals and Patients with Acute Myocardial Infarction as Assessed by Multiple Reaction Monitoring-Mass Spectrometry.

Polten F, Reboll MR, Widera C, Kempf T, Bethmann K, Gupta P, Miglietta J, Pekcec A, Tillmanns J, Bauersachs J, Giannitsis E, Pich A, Wollert KC.

Anal Chem. 2019 Jan 15;91(2):1302-1308. doi: 10.1021/acs.analchem.8b03041. Epub 2018 Dec 28.

PMID:
30543396
30.

The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy.

Hoevelmann J, Viljoen CA, Manning K, Baard J, Hahnle L, Ntsekhe M, Bauersachs J, Sliwa K.

Int J Cardiol. 2019 Feb 1;276:177-184. doi: 10.1016/j.ijcard.2018.11.008. Epub 2018 Nov 7.

PMID:
30497895
31.

Echocardiographic Changes in Patients Implanted With a Fully Magnetically Levitated Left Ventricular Assist Device (Heartmate 3).

Uriel N, Medvedofsky D, Imamura T, Maly J, Kruse E, Ivák P, Sood P, Lang RM, Maffessanti F, Berliner D, Bauersachs J, Haverich A, Želízko M, Netuka I, Schmitto JD.

J Card Fail. 2019 Jan;25(1):36-43. doi: 10.1016/j.cardfail.2018.11.015. Epub 2018 Nov 22.

PMID:
30472281
32.

[Update of the ESC guidelines 2018 on cardiovascular diseases during pregnancy : Most important facts].

Seeland U, Bauersachs J, Roos-Hesselink J, Regitz-Zagrosek V.

Herz. 2018 Dec;43(8):710-718. doi: 10.1007/s00059-018-4765-4. Review. German.

PMID:
30456631
33.

Of mice and men: models and mechanisms of diabetic cardiomyopathy.

Riehle C, Bauersachs J.

Basic Res Cardiol. 2018 Nov 15;114(1):2. doi: 10.1007/s00395-018-0711-0. Review.

34.

Corrigendum to "Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice" Journal of Molecular and Cellular Cardiology 122 (2018) 114-124.

Froese N, Wang H, Zwadlo C, Wang Y, Grund A, Gigina A, Hofmann M, Kilian K, Scharf G, Korf-Klingebiel M, Melchert A, Signorini MER, Halloin C, Zweigerdt R, Martin U, Gruh I, Wollert KC, Geffers R, Bauersachs J, Heineke J.

J Mol Cell Cardiol. 2018 Dec;125:205. doi: 10.1016/j.yjmcc.2018.11.003. Epub 2018 Nov 7. No abstract available.

PMID:
30414408
35.

Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR): consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRC.

Michels G, Wengenmayer T, Hagl C, Dohmen C, Böttiger BW, Bauersachs J, Markewitz A, Bauer A, Gräsner JT, Pfister R, Ghanem A, Busch HJ, Kreimeier U, Beckmann A, Fischer M, Kill C, Janssens U, Kluge S, Born F, Hoffmeister HM, Preusch M, Boeken U, Riessen R, Thiele H.

Clin Res Cardiol. 2019 May;108(5):455-464. doi: 10.1007/s00392-018-1366-4. Epub 2018 Sep 4. Review.

PMID:
30361819
36.

Blood-based microRNA profiling in patients with cardiac amyloidosis.

Derda AA, Pfanne A, Bär C, Schimmel K, Kennel PJ, Xiao K, Schulze PC, Bauersachs J, Thum T.

PLoS One. 2018 Oct 17;13(10):e0204235. doi: 10.1371/journal.pone.0204235. eCollection 2018.

37.

Treatments targeting inotropy.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A.

Eur Heart J. 2018 Oct 8. doi: 10.1093/eurheartj/ehy600. [Epub ahead of print]

PMID:
30295807
38.

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, González A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S.

Eur Heart J. 2018 Dec 21;39(48):4243-4254. doi: 10.1093/eurheartj/ehy596. No abstract available.

39.

Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.

Hilfiker-Kleiner D, Sliwa K, Bauersachs J.

Eur Heart J. 2018 Nov 14;39(43):3905. doi: 10.1093/eurheartj/ehy603. No abstract available.

PMID:
30272152
40.

Mortality in Patients With Out-of-Hospital Cardiac Arrest Undergoing a Standardized Protocol Including Therapeutic Hypothermia and Routine Coronary Angiography: Experience From the HACORE Registry.

Akin M, Sieweke JT, Zauner F, Garcheva V, Tongers J, Napp LC, Friedrich L, Treptau J, Bahntje MU, Flierl U, Sedding DG, Bauersachs J, Schäfer A.

JACC Cardiovasc Interv. 2018 Sep 24;11(18):1811-1820. doi: 10.1016/j.jcin.2018.06.022.

PMID:
30236353
41.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. No abstract available.

PMID:
30165544
42.

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.

Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, Winkler S, Vettorazzi E, Bruch L, Oeff M, Zugck C, Doerr G, Naegele H, Störk S, Butter C, Sechtem U, Angermann C, Gola G, Prondzinsky R, Edelmann F, Spethmann S, Schellong SM, Schulze PC, Bauersachs J, Wellge B, Schoebel C, Tajsic M, Dreger H, Anker SD, Stangl K.

Lancet. 2018 Sep 22;392(10152):1047-1057. doi: 10.1016/S0140-6736(18)31880-4. Epub 2018 Aug 25.

PMID:
30153985
43.

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.

Haghikia A, Schwab J, Vogel-Claussen J, Berliner D, Pfeffer T, König T, Zwadlo C, Moulig VA, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kühl U, Podewski E, Kindermann I, Böhm M, Sliwa K, Hilfiker-Kleiner D, Bauersachs J.

Clin Res Cardiol. 2019 Mar;108(3):290-297. doi: 10.1007/s00392-018-1355-7. Epub 2018 Aug 18.

44.

Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice.

Froese N, Wang H, Zwadlo C, Wang Y, Grund A, Gigina A, Hofmann M, Kilian K, Scharf G, Korf-Klingebiel M, Melchert A, Signorini MER, Halloin C, Zweigerdt R, Martin U, Gruh I, Wollert KC, Geffers R, Bauersachs J, Heineke J.

J Mol Cell Cardiol. 2018 Sep;122:114-124. doi: 10.1016/j.yjmcc.2018.08.011. Epub 2018 Aug 14. Erratum in: J Mol Cell Cardiol. 2018 Dec;125:205.

PMID:
30118791
45.

Long-Term Prognosis of Patients With Takotsubo Syndrome.

Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C.

J Am Coll Cardiol. 2018 Aug 21;72(8):874-882. doi: 10.1016/j.jacc.2018.06.016.

PMID:
30115226
46.

Heart failure 2.0 or 0.1?

Bauersachs J, Maisch B.

Herz. 2018 Aug;43(5):381-382. doi: 10.1007/s00059-018-4720-4. No abstract available.

PMID:
30073467
47.

Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity.

Chatterjee S, de Gonzalo-Calvo D, Derda AA, Schimmel K, Sonnenschein K, Bavendiek U, Bauersachs J, Bär C, Thum T.

Sci Rep. 2018 Jul 25;8(1):11227. doi: 10.1038/s41598-018-29072-8.

48.

[Policy paper nuclear cardiology - update 2018 - Current status of clinical practice].

Lindner O, Bauersachs J, Bengel FM, Burchert W, Vom Dahl J, Dörr R, Hacker M, Kelm M, Rassaf T, Rischpler C, Schäfer W, Schäfers MA, Silber S, Zimmermann R.

Nuklearmedizin. 2018 Aug;57(4):146-152. doi: 10.3413/2018-06-0001. Epub 2018 Jul 24. German.

PMID:
30041259
49.

Clinical care for patients with recurrent myocardial ischemia in Germany-the VOICES trial.

Berliner D, Maier LS, Wollenberg U, Limberg R, Schmitto JD, Westermann D, Bauersachs J.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1777-S1784. doi: 10.21037/jtd.2017.10.123.

50.

Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.

Hilfiker-Kleiner D, Sliwa K, Bauersachs J.

Eur Heart J. 2018 Oct 1;39(37):3478. doi: 10.1093/eurheartj/ehy406. No abstract available.

PMID:
30016421

Supplemental Content

Loading ...
Support Center